Episode Details
Back to Episodes
Discussing Rheumatology: Poor Prognostic Factors, Monotherapy, and Combination Therapy
Published 4 years, 8 months ago
Description
Prof Iain McInnes discusses poor prognostics factors from the FINCH 3 study, and the effectiveness and persistence of monotherapy and combination therapy from the Australian OPAL study.
Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.